Arbutus Biopharma Corporation logo ABUS - Arbutus Biopharma Corporation

Price: -- -- | CONSENSUS: Buy DETAILS
STRONG
BUY
0
BUY 8
HOLD 2
SELL 0
STRONG
SELL
0
| PRICE TARGET: $8.50 DETAILS
HIGH: $8.50
LOW: $8.50
MEDIAN: $8.50
CONSENSUS: $8.50
UPSIDE: 95.40%
Metric 2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003 2002 2001 2000 1999 1998
Revenue
Revenue 14.1 6.2 18.1 39.0 11.0 6.9 6.0 5.9 10.7 1.5 24.9 15 15.5 14.2 16.3 21.4 13.8 9.6 15.9 13.6 13.3 12.2 2.7 5.1 3.5 1.8 1.1 1.2
Cost of Revenue 0.4 0 0 0 0 47.5 57.6 57.9 62.7 61.3 51.5 38.7 21.5 18.1 19.5 22.1 17.0 13.2 0 6.2 0 0 0 0 0 0 0 0
Gross Profit 13.7 6.2 18.1 39.0 11.0 (40.6) (51.6) (52) (52) (59.8) (26.6) (23.7) (6.0) (3.9) (3.2) (0.8) (3.2) (3.6) 15.9 7.4 13.3 12.2 2.7 5.1 3.5 1.8 1.1 1.2
Operating Expenses
R&D Expenses 25.2 54.0 73.7 84.4 65.5 49.3 57.6 57.9 62.7 61.3 51.5 38.7 21.5 18.1 0 22,133,983 0 0 8.4 4.5 8.8 22.3 23.7 21.6 12.8 8.7 7.7 8.7
SG&A Expenses 15.9 22.1 22.5 17.8 17.1 14.8 17.7 16 16.1 39.4 26.4 8.7 5.5 26.9 6.2 4.8 4.0 3.6 4.4 3.9 3.8 7.8 6.8 5.5 3.1 2.3 1.6 1.3
Other Expenses (0.4) 6.3 0.1 2.2 1.9 (46.9) 17.0 7.3 2.2 2.5 (0.8) (5.8) 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Operating Expenses 40.8 82.5 96.2 104.5 84.5 17.2 92.3 76.1 80.8 101.8 78.5 47.9 27.6 (19.5) 7.1 11.7 5.9 4.7 13.3 9.1 14.4 35.6 37.4 32.8 19.9 11.0 9.3 10.0
Operating Income
Operating Income (27.1) (76.3) (78.1) (65.5) (73.5) (57.8) (143.9) (89.8) (110.9) (491.6) (102.3) (33) (12.2) (13.0) (10.3) (12.5) (9.1) (10.9) 2.6 (1.7) (6.0) (27.6) (34.6) (27.7) (16.4) (9.2) (8.2) (8.8)
Interest Expense 0.1 0.1 0.5 1.7 2.9 4.0 2.1 0.2 0.3 0 0 0 0 0.0 0.1 0 0 0 0 1.6 0 0 0 0 0 0 0 0
Interest Income 4.1 6.6 5.7 2.2 0.1 0.7 2.1 3 1.5 1.4 0.7 0.9 0.5 0.1 0.1 0.1 0.2 0.7 1.0 0.3 0.4 0.8 1.1 1.0 1.0 0 0 0
Profitability
EBITDA (26.7) (68.4) (71.0) (61.9) (71.6) (57.8) (162.2) (59.0) (106.4) (488.1) (76.7) (32.4) (11.5) 34.2 (9.1) (11.0) (6.7) (7.2) 3.1 21.0 1.3 (17.9) (27.8) (22.1) (12.6) (9.4) (6.9) (7.8)
EBIT (27.1) (69.8) (72.4) (63.3) (73.4) (59.7) (164.3) (61.1) (108.5) (489.2) (78.9) (33.0) (12.2) 33.3 (10.0) (6.6) (8.1) (8.3) 2.6 20.2 (1.1) (23.4) (34.6) (23.9) (16.5) (10.7) (8.2) (8.8)
Income Before Tax (33.5) (69.9) (72.8) (65.0) (76.2) (63.7) (166.4) (61.4) (108.7) (489.1) (77.3) (38.7) (14.1) 29.9 (9.9) (12.5) (9.5) (11.7) (2.6) 18.1 (7.7) (29.8) 0 0 (16.0) 0 0 0
Income Tax Expense 0 0 0 4.4 0 0 (12.7) (4.3) (24.3) (105) (16.2) 0.1 1.9 3.7 (0.6) (0.1) 0.3 0 0 (0.0) 0.4 8.9 (0.5) (0.9) (2.3) 0 0 0
Net Income (33.5) (69.9) (72.8) (69.5) (76.2) (63.7) (153.7) (57.1) (84.4) (384.1) (61.1) (38.8) (14.1) 29.9 (9.7) (12.4) (9.3) (11.7) (2.6) 18.1 (8.1) (28.0) (34.1) (26.8) (14.0) (9.2) (8.2) (8.8)
Per Share Data
EPS (Basic) -0.17 -0.38 -0.44 -0.46 -0.73 -0.86 -2.69 -1.03 -1.54 -7.24 -1.34 -1.80 -0.92 2.16 -0.86 -1.20 -0.90 -1.44 -0.54 4.68 -1.04 -3.64 -4.78 -4.08 -2.76 -1.87 -2.90 -4.05
EPS (Diluted) -0.17 -0.38 -0.44 -0.46 -0.73 -0.86 -2.69 -1.03 -1.54 -7.24 -1.34 -1.73 -0.92 2.07 -0.86 -1.20 -0.90 -1.44 -0.54 4.68 -1.04 -3.64 -4.78 -4.08 -2.76 -1.87 -2.90 -4.05
Shares Outstanding 191.6 185.6 166.0 150.9 106.2 75.8 57.1 55.3 54.7 53.1 45.4 21.6 15.3 13.7 11.3 10.3 10.3 8.1 4.8 3.9 7.7 7.7 7.1 6.6 5.1 4.9 2.8 2.2
Metric 2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2009 2008 2004 2003 2002 2001 2000 1999 1998
Current Assets
Cash & Cash Equivalents 18.0 36.3 26.3 30.8 109.3 52.3 31.8 36.9 54.3 23.4 23.3 21.5 25.0 35.6 20.5 25.6 2.0 10.9 0.8
Short-Term Investments 73.5 86.3 99.7 116.1 46.0 71.0 59.0 87.7 72.1 107.1 0 4.7 0 3.6 17.7 21.9 21.9 8.7 5.7
Net Receivables 1.7 2.4 1.8 1.4 0.9 1.3 1.2 1.4 0.9 0.7 1.3 0.8 1.8 0.4 0.5 2.0 0.8 0.5 0.2
Inventory 0 0 0 0 0 0 0 0 0 0 0 0.1 0.3 0 0 0 0.2 0 0
Other Current Assets 1.2 2.3 4.2 2.9 0 0 0 0 0.3 0.3 0 0.1 1.7 0.5 0 0 0 0 0.1
Total Current Assets 94.5 127.3 132.0 151.1 160.7 127.7 93.8 129.2 129.4 132.6 24.8 27.3 28.7 40.1 38.9 49.8 25.2 20.2 6.8
Non-Current Assets
Property, Plant & Equipment 0.0 4.4 6.1 6.8 8.1 9.3 11.4 10.1 12.2 6.9 2.7 2.1 3.4 4.1 3.7 2.8 2.4 2.9 3.0
Goodwill 0 0 0 0 0 0 0 22.5 24.4 24.4 0 0 0 0 0 0 0 0 0
Intangible Assets 0 0 0 0 0 0 0 43.8 58.6 99.4 14.5 12.9 1.8 0.4 0.5 2.0 0.8 0.5 0.2
Long-Term Investments 0 0 6.3 37.4 35.7 0 0 22.2 12.6 12.6 0 0 0.6 1.5 2.1 2.2 0.2 0.2 0.2
Other Non-Current Assets 0.1 0.0 0 0.1 0.1 0.0 0.3 22.2 12.6 12.6 0 0 1.2 0.2 0 15.0 4.9 5.7 6.0
Total Non-Current Assets 0.2 4.4 12.4 44.3 43.8 9.4 11.7 98.7 107.8 143.3 17.2 15.0 12.4 10.6 14.3 17.8 7.3 8.6 9.0
Total Assets 94.6 131.7 144.4 195.4 204.5 137.1 105.5 227.9 237.2 275.9 41.9 42.3 41.1 50.7 53.2 67.6 32.5 28.8 15.8
Current Liabilities
Account Payables 1.2 2.3 3.2 3.5 3.2 3.0 2.4 3.2 2.0 3.2 2.0 0.5 0.9 0 0 0 0 0 0
Short-Term Debt 0.5 0 0 0.4 0 0 0 0 0 0 0 0 0.7 0.3 0 0 0 0 0
Deferred Revenue 0 7.6 11.8 16.5 0 0 0 0 2.7 0.0 1.1 0.4 0 0 0 0 0 0 0
Other Current Liabilities 4.3 0 3.7 8.8 0 0 0.3 5.7 7.0 5.2 0.0 0.2 9.2 4.1 4.7 2.5 1.9 1.3 0.8
Total Current Liabilities 6.0 15.6 22.5 32.9 11.2 9.5 7.8 11.2 11.9 10.6 6.5 4.1 10.9 4.5 4.8 2.6 1.9 1.3 0.8
Non-Current Liabilities
Long-Term Debt 3.4 0 7.0 10.4 16.3 19.6 0 0 12.0 12.0 0 0 0.9 0.6 0 0 0 0 0
Deferred Tax Liabilities 0 0 0 0 0 0 0 12.7 16.9 41.2 0 0 0.0 0 0 0 0 0 0
Other Non-Current Liabilities 8.4 15.1 7.6 7.5 5.3 3.4 3.0 3.8 28.1 50.3 0 0 32.3 2.0 2.6 2.7 0.5 0.5 0.6
Total Non-Current Liabilities 12.0 18.7 15.9 25.7 23.8 25.6 25.0 16.4 42.8 62.3 0 0 40.7 2.8 3.1 3.5 0.6 0.6 0.6
Total Liabilities 18.0 34.3 38.4 58.6 35.0 35.1 32.8 27.7 54.7 72.9 6.5 4.1 51.6 7.3 7.9 6.1 2.5 1.9 1.4
Stockholders' Equity
Common Stock 1,421.4 1,410.0 1,349.8 1,318.7 1,286.6 985.9 898.5 879.4 876.1 867.4 0 0 149.9 138.1 96.1 94.8 68.2 56.9 35.0
Retained Earnings (1,380.1) (1,346.6) (1,276.7) (1,203.8) (1,134.3) (1,046.0) (970.1) (805.2) (738.1) (651.1) (211.9) (174.3) (177.1) (142.5) (79.6) (50.6) (38.2) (30.0) (20.5)
Accumulated Other Comprehensive Income (48.1) (48.1) (48.4) (50.5) (48.3) (48.2) (48.2) (48.2) (48.2) (49.8) (11.9) (11.6) 0 0 0 0 0 0 0
Total Stockholders' Equity 76.6 97.4 106.0 136.9 169.4 102.0 72.7 200.2 182.5 203 35.4 38.3 (10.5) 43.4 45.3 61.5 30.0 26.9 14.4
Total Liabilities & Equity 94.6 131.7 144.4 195.4 204.5 137.1 105.5 227.9 237.2 275.9 41.9 42.3 41.1 50.7 53.2 67.6 32.5 28.8 15.8
Debt Metrics
Total Debt 4.2 1.3 8.7 12.6 18.9 22.5 3.4 0 12 12 0 0 1.8 1.2 0.3 0.4 0.1 0.1 0
Net Debt (13.8) (35.0) (17.6) (18.2) (90.4) (29.7) (28.4) (36.9) (42.3) (11.4) (23.3) (21.5) (23.2) (34.3) (20.2) (25.3) (1.9) (10.8) (0.8)
Metric 2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2005 2004 2003 2002 2001 2000 1999 1998
Operating Activities
Net Income (33.5) (69.9) (72.8) (69.5) (76.2) (63.7) (153.7) (57.1) (84.4) (384.2) (8.1) (28.0) (34.1) (26.8) (14.0) (9.2) (8.2) (8.8)
Depreciation & Amortization 0.4 1.4 1.4 1.4 1.8 2.0 2.0 2.2 2.0 1.1 2.4 1.2 6.8 5.6 3.9 1.3 1.3 1.0
Stock-Based Compensation 7.0 9.0 9.3 7.2 6.4 6.2 6.8 6.2 15.1 39.2 0 0 0 0 0 0 0 0
Change in Working Capital (10.0) (2.8) (18.2) 29.2 0.9 0.4 (2.2) (4.3) 3.1 (0.5) (3.1) 1.6 (2.0) 2.8 (0.2) 0.1 0.0 0.1
Other Non-Cash Items (3.4) (2.5) (5.6) (3.8) 7.8 3.7 88.8 (10.7) 39.8 391.6 (5.8) 15.2 2.3 0.2 0.4 (0.5) 0.0 0
Operating Cash Flow (39.6) (64.8) (85.9) (35.4) (67.5) (51.4) (71.0) (67.9) (48.6) (57.9) (14.6) (10.0) (27.0) (18.2) (10.0) (8.4) (6.8) (7.7)
Investing Activities
Capital Expenditure 0 (0.2) (1.0) (0.5) (0.8) (0.2) (0.6) (1.1) (7.3) (4.0) (0.0) (7.1) (0.8) (2.0) (0.9) (0.2) (0.3) (3.2)
Acquisitions 0 0 0 0 1.8 (2.5) 0 0.0 0.0 0.0 0 0 0 0 0 0 0 0
Purchases of Investments 12.9 (141.5) (80.5) (130.4) (82.2) (85.6) (58.8) (3.0) 0 (95.2) 0 0 0 0 (1.0) (13.0) (2.7) 0
Sales/Maturities of Investments 155.3 164.6 132.3 56 70.3 73.4 87.7 0 35.1 0 0 3.9 17.8 0 0 0 0 10.3
Other Investing Activities (152.6) 0 0.0 0 (1.8) 0 0.0 (3.0) 35.1 0.0 0.4 (1.0) 0 4.9 0.1 0 0.0 0.1
Investing Cash Flow 15.6 22.9 50.8 (74.9) (12.7) (14.9) 28.3 (4.1) 27.8 (99.1) 0.4 (4.2) 17.0 3.0 (1.9) (13.2) (3.0) 7.1
Financing Activities
Net Debt Issuance 0 0 0 0 0 0 0 (12.0) 0 12.0 (1.2) (0.0) 0.5 (0.2) (0.1) (0.0) 0 0
Stock Repurchased 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Dividends Paid 0 0 0 0 (12.1) 0 0 (10.1) 0 0 0 0 0 0 0 0 0 0
Other Financing Activities 0 7.9 0.8 11.5 14.7 0.4 18.9 11.5 0.5 0.6 0 0.2 0 9.7 5.1 0 0 0
Financing Cash Flow 5.7 52.0 30.6 31.8 137.2 86.7 37.5 55.6 49.3 12.6 (1.2) 0.8 20.6 9.8 35.6 13.1 19.9 0.0
Cash Position
Net Change in Cash (18.3) 10.0 (4.5) (78.5) 57.0 20.5 (5.1) (17.4) 30.9 (143.4) (15.4) (13.4) 10.7 (5.4) 23.7 (8.5) 10.1 (0.5)
Cash at Beginning 36.3 26.3 30.8 109.3 52.3 31.8 36.9 54.3 23.4 166.8 25.9 38.4 24.9 25.9 1.9 10.5 0.8 1.3
Cash at End 18.0 36.3 26.3 30.8 109.3 52.3 31.8 36.9 54.3 23.4 10.5 25.0 35.6 20.5 25.6 2.0 10.9 0.8
Free Cash Flow (39.6) (65.0) (86.9) (35.9) (68.3) (51.7) (71.6) (69.0) (55.9) (61.9) (14.6) (17.1) (27.8) (20.1) (10.9) (8.6) (7.1) (10.9)
Key Metrics 2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003 2002 2001 2000 1999 1998
Income Statement
Revenue 14.1 6.2 18.1 39.0 11.0 6.9 6.0 5.9 10.7 1.5 24.9 15 15.5 14.2 16.3 21.4 13.8 9.6 15.9 13.6 13.3 12.2 2.7 5.1 3.5 1.8 1.1 1.2
Gross Profit 13.7 6.2 18.1 39.0 11.0 (40.6) (51.6) (52) (52) (59.8) (26.6) (23.7) (6.0) (3.9) (3.2) (0.8) (3.2) (3.6) 15.9 7.4 13.3 12.2 2.7 5.1 3.5 1.8 1.1 1.2
Operating Income (27.1) (76.3) (78.1) (65.5) (73.5) (57.8) (143.9) (89.8) (110.9) (491.6) (102.3) (33) (12.2) (13.0) (10.3) (12.5) (9.1) (10.9) 2.6 (1.7) (6.0) (27.6) (34.6) (27.7) (16.4) (9.2) (8.2) (8.8)
Net Income (33.5) (69.9) (72.8) (69.5) (76.2) (63.7) (153.7) (57.1) (84.4) (384.1) (61.1) (38.8) (14.1) 29.9 (9.7) (12.4) (9.3) (11.7) (2.6) 18.1 (8.1) (28.0) (34.1) (26.8) (14.0) (9.2) (8.2) (8.8)
EPS (Diluted) -0.17 -0.38 -0.44 -0.46 -0.73 -0.86 -2.69 -1.03 -1.54 -7.24 -1.34 -1.73 -0.92 2.07 -0.86 -1.20 -0.90 -1.44 -0.54 4.68 -1.04 -3.64 -4.78 -4.08 -2.76 -1.87 -2.90 -4.05
Balance Sheet
Cash & Equivalents 18.0 36.3 26.3 30.8 109.3 52.3 31.8 36.9 54.3 23.4 23.3 21.5 25.0 35.6 20.5 25.6 2.0 10.9 0.8
Total Assets 94.6 131.7 144.4 195.4 204.5 137.1 105.5 227.9 237.2 275.9 41.9 42.3 41.1 50.7 53.2 67.6 32.5 28.8 15.8
Total Debt 4.2 1.3 8.7 12.6 18.9 22.5 3.4 0 12 12 0 0 1.8 1.2 0.3 0.4 0.1 0.1 0
Stockholders' Equity 76.6 97.4 106.0 136.9 169.4 102.0 72.7 200.2 182.5 203 35.4 38.3 (10.5) 43.4 45.3 61.5 30.0 26.9 14.4
Cash Flow
Operating Cash Flow (39.6) (64.8) (85.9) (35.4) (67.5) (51.4) (71.0) (67.9) (48.6) (57.9) (14.6) (10.0) (27.0) (18.2) (10.0) (8.4) (6.8) (7.7)
Capital Expenditure 0 (0.2) (1.0) (0.5) (0.8) (0.2) (0.6) (1.1) (7.3) (4.0) (0.0) (7.1) (0.8) (2.0) (0.9) (0.2) (0.3) (3.2)
Free Cash Flow (39.6) (65.0) (86.9) (35.9) (68.3) (51.7) (71.6) (69.0) (55.9) (61.9) (14.6) (17.1) (27.8) (20.1) (10.9) (8.6) (7.1) (10.9)